Well, unfortunately they posted on seeking alpha a

Well, unfortunately they posted on seeking alpha also, which I read this morning. I had escaped them until now on iHub, not reading that board. So I read their ‘report’. They are still worried about the RP patents, still worried about not enough safety data at 700mg, and are quoting January numbers from the 700mg, trying to work some math, when the enrollment has tripled.

https://content.equisolve.net/_09215011a78c20..._Final.pdf
24.62% (48/195) of patients treated with 525 mg PRO 140 experienced virologic failure.
18.55% (23/124) of patients treated with 700 mg PRO 140 experienced virologic failure.

They feel the 525mg should be abandoned, when the FDA was the one that told the company not to abandon 525mg, especially with new longer overlap, remember most failures are happening here.







They use words like ‘claim’ to have

Quote:

---

CYDY claims initial paperwork has been submitted , i.e. 1/3 parts

---

They love Thompson, who was a lead on the first team before Cydy that failed pro 140. She should have figured out this safety data years ago and this drug would already be approved, without NP having to rescue it off a shelf. Heck, Thompson couldn’t even get the half life calculated, only off by 7 days. Somehow though in their eyes, she succeeded and Cydy has failed.